|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/4184 | (2006.01) |
| A61K 9/0019 | (2013.01) | ||
| A61K 47/10 | (2017.01) | ||
| A61K 31/4184 | (2013.01) | ||
| A61K 47/20 | (2006.01) | ||
| A61K 47/10 | (2013.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/02 | (2018.01) |
| (11) | Patento numeris | 2827862 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13764989.3 |
| Europos patento paraiškos padavimo data | 2013-03-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-01-28 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-12-27 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/032289 |
| Data | 2013-03-15 |
| (87) | Numeris | WO 2013/142358 |
| Data | 2013-09-26 |
| (30) | Numeris | Data | Šalis |
| 201261613173 P | 2012-03-20 | US | |
| 201261669889 P | 2012-07-10 | US |
| (72) |
SUNDARAM, Srikanth , US
|
| (73) |
Eagle Pharmaceuticals, Inc. ,
50 Tice Boulevard
Suite 315, Woodcliff Lake, NJ 07677,
US
|
| (54) | FORMULATIONS OF BENDAMUSTINE |
| FORMULATIONS OF BENDAMUSTINE |